Login / Signup

Number of metastatic organs negatively affects the treatment sequence in patients with EGFR-TKI failure.

Takaaki MizunoHidehito HorinouchiSho WatanabeJun SatoRyo MoritaShuji MurakamiYasushi GotoShintaro KandaYutaka FujiwaraNoboru YamamotoYuichiro Ohe
Published in: Thoracic cancer (2020)
A relatively large number of metastatic organs and a poor PS were associated with the withholding of subsequent chemotherapy after failure of EGFR-TKI in EGFR-mutated NSCLC patients. Further research for patients with such a poor prognosis should be investigated in the future.
Keyphrases